AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 22519750 — intervention group
Group type: EXPERIMENTAL
Intervention: Frequency of communication
Number of subjects: 1478
Study 22519750 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality of communication
Number of subjects: 1478
Study 22519750 — intervention group
Group type: EXPERIMENTAL
Intervention: Pro-smoking attitudes
Number of subjects: 1478
Study 20716074 — intervention group
Group type: EXPERIMENTAL
Intervention: Insufflation (Group I)
Number of subjects: 415
Study 20716074 — intervention group
Group type: COMPARATOR
Intervention: Intubation/awake extubation (Group A)
Number of subjects: 415
Study 20716074 — intervention group
Group type: COMPARATOR
Intervention: Intubation/deep extubation (Group D)
Number of subjects: 415
Study 17953678 — intervention group
Group type: EXPERIMENTAL
Intervention: Neutral pH superoxidised aqueous solution (NpHSS)
Number of subjects: 45
Study 16288379 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV-infected patients
Number of subjects: 528
Study 12429535 — intervention group
Group type: EXPERIMENTAL
Intervention: Methotrexate (MTX) treatment starting at 7.5 mg/week, increased to a maximum of 25 mg/week if necessary
Number of subjects: 103
Study 12429535 — intervention group
Group type: EXPERIMENTAL
Intervention: Methotrexate (MTX) treatment
Number of subjects: 103
Study 9449399 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenylephrine
Number of subjects: 8
Study 9449399 — intervention group
Group type: EXPERIMENTAL
Intervention: Angiotensin II
Number of subjects: 8
Study 9449399 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoproterenol
Number of subjects: 8
Study 9449399 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 8586074 — intervention group
Group type: EXPERIMENTAL
Intervention: Sandpaper handle with 4.2 kg load
Number of subjects: 10
Study 8586074 — intervention group
Group type: EXPERIMENTAL
Intervention: Smooth aluminum handle with 4.2 kg load
Number of subjects: 10
Study 8586074 — intervention group
Group type: EXPERIMENTAL
Intervention: Sandpaper handle with lower loads (0.8 kg and 2.5 kg)
Number of subjects: 10
Study 8586074 — intervention group
Group type: EXPERIMENTAL
Intervention: Smooth aluminum handle with lower loads (0.8 kg and 2.5 kg)
Number of subjects: 10
Study 2121507 — intervention group
Group type: EXPERIMENTAL
Intervention: Monounsaturated diet (15.1% energy from monounsaturated and 7.9% from polyunsaturated fatty acids)
Number of subjects: 58
Study 2121507 — intervention group
Group type: COMPARATOR
Intervention: Polyunsaturated fatty acid-enriched diet (10.8% from monounsaturated and 12.7% from polyunsaturated fatty acids)
Number of subjects: 58
Study 2121507 — intervention group
Group type: COMPARATOR
Intervention: Control diet (19.3% of energy as saturated fat)
Number of subjects: 58
Study 402671 — intervention group
Group type: EXPERIMENTAL
Intervention: Tricyclic antidepressants (imipramine and amitriptyline)
Number of subjects: 0
Study 402671 — intervention group
Group type: COMPARATOR
Intervention: Control (baseline prolactin levels)
Number of subjects: 0
Study 31267573 — intervention group
Group type: EXPERIMENTAL
Intervention: HbA1c levels
Number of subjects: 530
Study 29070160 — intervention group
Group type: EXPERIMENTAL
Intervention: Ca3SiO5-based dentin substitute
Number of subjects: 80
Study 29070160 — intervention group
Group type: COMPARATOR
Intervention: Ca(OH)2-based liner
Number of subjects: 80
Study 24770382 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-bundle ACL reconstruction with modified bone-patellar tendon-bone (BPTB) allograft
Number of subjects: 94
Study 24770382 — intervention group
Group type: COMPARATOR
Intervention: Double-bundle ACL reconstruction with tibialis anterior allograft
Number of subjects: 94
Study 24770382 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-bundle ACL reconstruction with modified BPTB allograft
Number of subjects: 94
Study 23889217 — intervention group
Group type: EXPERIMENTAL
Intervention: DHEA supplementation (3 tablets daily of 25 mg micronized DHEA for at least 12 weeks) in young women under 40 years
Number of subjects: 77
Study 23889217 — intervention group
Group type: EXPERIMENTAL
Intervention: DHEA supplementation (3 tablets daily of 25 mg micronized DHEA for at least 12 weeks) in women over 40 years
Number of subjects: 77
Study 23889217 — intervention group
Group type: COMPARATOR
Intervention: Control group (24 women over 40 years not treated with DHEA)
Number of subjects: 77
Study 23080088 — intervention group
Group type: EXPERIMENTAL
Intervention: Bare Metal Stent (BMS) - Chopin II(TM), Balton, Poland
Number of subjects: 111
Study 23080088 — intervention group
Group type: COMPARATOR
Intervention: Drug Eluting Stent (DES) - Paclitaxel eluting stent (Chopin Luc(TM), Balton, Poland)
Number of subjects: 111
Study 19032573 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine (0.5 mg/kg s.c.) administered via 10 injections every second day starting from postnatal day 27 for adolescents and day 75 for adults.
Number of subjects: 0
Study 19032573 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine (0.5 mg/kg) administered to challenge animals after initial treatment.
Number of subjects: 0
Study 19032573 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified, but comparisons made between adolescent and adult rats.
Number of subjects: 0
Study 17465948 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood Conservation Algorithm (BCA)
Number of subjects: 60
Study 17465948 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 60
Study 15009842 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin (5-days treatment)
Number of subjects: 25
Study 15009842 — intervention group
Group type: COMPARATOR
Intervention: Metronidazole (7-days treatment)
Number of subjects: 25
Study 11152432 — intervention group
Group type: EXPERIMENTAL
Intervention: Single dose of azithromycin (1.5 g)
Number of subjects: 12
Study 11152432 — intervention group
Group type: COMPARATOR
Intervention: 3 day regimen of azithromycin (500 mg/day)
Number of subjects: 12
Study 9471423 — intervention group
Group type: EXPERIMENTAL
Intervention: Octreotide 100 micrograms subcutaneously, three times daily for two days
Number of subjects: 8
Study 9471423 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 7952561 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical antimicrobial prophylaxis (TAP) with tobramycin, colistin, and amphotericin B administered in oropharynx and stomach.
Number of subjects: 97
Study 7952561 — intervention group
Group type: COMPARATOR
Intervention: No topical antimicrobial prophylaxis (Control Group 2).
Number of subjects: 97
Study 7952561 — intervention group
Group type: COMPARATOR
Intervention: No topical antimicrobial prophylaxis (Control Group 3).
Number of subjects: 97
Study 7952561 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical antimicrobial prophylaxis (TAP) (Group 1).
Number of subjects: 97
Study 3608351 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 mg intravenous trazodone
Number of subjects: 43
Study 3608351 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg oral trazodone
Number of subjects: 43
Study 3608351 — intervention group
Group type: COMPARATOR
Intervention: Obese subjects (mean weight 112 kg)
Number of subjects: 43
Study 30425247 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-gluten diet (2 g gluten per day)
Number of subjects: 60
Study 30425247 — intervention group
Group type: COMPARATOR
Intervention: High-gluten diet (18 g gluten per day)
Number of subjects: 60
Study 27076370 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine (intravenous bolus of 1.5 mg/kg at induction of anesthesia, followed by an infusion of 1.5 mg · kg · h until 30 minutes after PACU arrival)
Number of subjects: 80
Study 27076370 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study 25147326 — intervention group
Group type: EXPERIMENTAL
Intervention: Target systolic BP <150 mm Hg (n=37; SBP 140±18 mm Hg)
Number of subjects: 75
Study 25147326 — intervention group
Group type: COMPARATOR
Intervention: Target systolic BP <180 mm Hg (n=36; SBP 162±12 mm Hg)
Number of subjects: 75
Study 25147326 — intervention group
Group type: EXPERIMENTAL
Intervention: Target systolic BP <150 mm Hg (n=37)
Number of subjects: 75
Study 25147326 — intervention group
Group type: COMPARATOR
Intervention: Target systolic BP <180 mm Hg (n=36)
Number of subjects: 75
Study 22251024 — intervention group
Group type: EXPERIMENTAL
Intervention: Trazodone
Number of subjects: 0
Study 22251024 — intervention group
Group type: COMPARATOR
Intervention: Other sleep medications
Number of subjects: 0
Study 20674640 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking (moderate-intensity for approximately 40 min)
Number of subjects: 19
Study 20674640 — intervention group
Group type: COMPARATOR
Intervention: Rest
Number of subjects: 19
Study 18399256 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral immunonutrition (Impact Oral) for 7-10 days before surgery
Number of subjects: 153
Study 18399256 — intervention group
Group type: COMPARATOR
Intervention: No nutritional support
Number of subjects: 153
Study 18399256 — intervention group
Group type: COMPARATOR
Intervention: Normal group (without malnutrition)
Number of subjects: 153
Study 18399256 — intervention group
Group type: COMPARATOR
Intervention: Serum albuminemia <2.8 gr/dl
Number of subjects: 153
Study 18399256 — intervention group
Group type: COMPARATOR
Intervention: Lymphocyte count <1.500 mm3
Number of subjects: 153
Study 16036166 — intervention group
Group type: EXPERIMENTAL
Intervention: Histamine 10(-2)M
Number of subjects: 7
Study 16036166 — intervention group
Group type: EXPERIMENTAL
Intervention: Histamine 10(-22)M
Number of subjects: 7
Study 16036166 — intervention group
Group type: COMPARATOR
Intervention: Water controls
Number of subjects: 7
Study 11837826 — intervention group
Group type: EXPERIMENTAL
Intervention: Gotfried percutaneous compression plate (PCCP)
Number of subjects: 111
Study 11837826 — intervention group
Group type: COMPARATOR
Intervention: Classic hip screw (CHS)
Number of subjects: 111
Study 10066840 — intervention group
Group type: EXPERIMENTAL
Intervention: Nadroparin (180 anti-factor Xa units/kg per 24 hours) for 3 weeks
Number of subjects: 60
Study 10066840 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 3 weeks
Number of subjects: 60
Study 10066840 — intervention group
Group type: EXPERIMENTAL
Intervention: Nadroparin (180 anti-factor Xa units/kg per 24 hours) for 3 weeks followed by oral anticoagulants for 3 months
Number of subjects: 60
Study 7717368 — intervention group
Group type: EXPERIMENTAL
Intervention: Decision board
Number of subjects: 42
Study 7717368 — intervention group
Group type: COMPARATOR
Intervention: Short version of the instrument
Number of subjects: 42
Study 2292630 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive‐behavioral alcohol skills training
Number of subjects: 36
Study 2292630 — intervention group
Group type: COMPARATOR
Intervention: Didactic alcohol information program
Number of subjects: 36
Study 2292630 — intervention group
Group type: COMPARATOR
Intervention: Assessment only
Number of subjects: 36
Study 7030714 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-nitrox (200 to 250 mg, mean 3 mg/kg of body weight)
Number of subjects: 8
Study 7030714 — intervention group
Group type: COMPARATOR
Intervention: 5-nok (administered under the same conditions)
Number of subjects: 8
Study 31420374 — intervention group
Group type: EXPERIMENTAL
Intervention: High-emotion-arousing PWLs
Number of subjects: 1503
Study 31420374 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-emotion-arousing PWLs
Number of subjects: 1503
Study 31420374 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative emotions
Number of subjects: 1503
Study 31420374 — intervention group
Group type: COMPARATOR
Intervention: PWLs
Number of subjects: 1503
Study 30743037 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D printed models (3DPMs)
Number of subjects: 60
Study 30743037 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D images (3DIs)
Number of subjects: 60
Study 30743037 — intervention group
Group type: COMPARATOR
Intervention: 2D images (2DIs)
Number of subjects: 60
Study 27967333 — intervention group
Group type: EXPERIMENTAL
Intervention: Cemented total hip replacement (THR)
Number of subjects: 69
Study 27967333 — intervention group
Group type: COMPARATOR
Intervention: Uncemented total hip replacement (THR)
Number of subjects: 69
Study 26358535 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity intervention
Number of subjects: 436
Study 26358535 — intervention group
Group type: COMPARATOR
Intervention: Cancer screening comparison condition
Number of subjects: 436
Study 23418103 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight loss intervention over 12 months
Number of subjects: 374
Study 23418103 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetic predisposition scores (GPS) for total cholesterol (TC)
Number of subjects: 374
Study 23418103 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetic predisposition scores (GPS) for low density lipoprotein cholesterol (LDLC)
Number of subjects: 374
Study 23418103 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetic predisposition scores (GPS) for high density lipoprotein cholesterol (HDLC)
Number of subjects: 374
Study 23418103 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetic predisposition scores (GPS) for triglycerides (TG)
Number of subjects: 374
Study 21690460 — intervention group
Group type: EXPERIMENTAL
Intervention: onabotulinumtoxinA (10 U)
Number of subjects: 90
Study 21690460 — intervention group
Group type: COMPARATOR
Intervention: abobotulinumtoxinA (30 U)
Number of subjects: 90
Study 19909548 — intervention group
Group type: EXPERIMENTAL
Intervention: Certolizumab pegol (CZP) plus methotrexate (MTX)
Number of subjects: 982
Study 19909548 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PBO) plus methotrexate (MTX)
Number of subjects: 982
Study 17910331 — intervention group
Group type: EXPERIMENTAL
Intervention: Azelastine nasal spray, 1 spray per nostril twice daily
Number of subjects: 554
Study 17910331 — intervention group
Group type: COMPARATOR
Intervention: Placebo nasal spray
Number of subjects: 554
Study 15475903 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-steroidal anti-inflammatory drugs (NSAIDs)
Number of subjects: 100
Study 15475903 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclo-oxygenase-2 (COX-2) inhibitors
Number of subjects: 100
Study 15475903 — intervention group
Group type: EXPERIMENTAL
Intervention: Paracetamol 600/650 mg plus codeine 60 mg
Number of subjects: 100
Study 15475903 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 11796077 — intervention group
Group type: EXPERIMENTAL
Intervention: Relaxing music (Pachelbel's Canon in D major)
Number of subjects: 87
Study 11796077 — intervention group
Group type: COMPARATOR
Intervention: Silence (Control)
Number of subjects: 87
Study 11796077 — intervention group
Group type: EXPERIMENTAL
Intervention: Relaxing music
Number of subjects: 87
Study 9760898 — intervention group
Group type: EXPERIMENTAL
Intervention: TiO‐blasted implants
Number of subjects: 50
Study 9760898 — intervention group
Group type: COMPARATOR
Intervention: Machined implants
Number of subjects: 50
Study 9760898 — intervention group
Group type: EXPERIMENTAL
Intervention: Both types of implants
Number of subjects: 50
Study 7802196 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma‐Lyte 148 (magnesium‐containing crystalloid solution)
Number of subjects: 30
Study 7802196 — intervention group
Group type: COMPARATOR
Intervention: Compound sodium lactate solution (maintenance crystalloid)
Number of subjects: 30
Study 2973169 — intervention group
Group type: EXPERIMENTAL
Intervention: Orchiectomy plus antiandrogen Flutamide
Number of subjects: 99
Study 2973169 — intervention group
Group type: EXPERIMENTAL
Intervention: Depot LH‐RH analog Zoladex plus Flutamide
Number of subjects: 99
Study 2973169 — intervention group
Group type: COMPARATOR
Intervention: Orchiectomy alone
Number of subjects: 99
Study 2973169 — intervention group
Group type: COMPARATOR
Intervention: Zoladex alone
Number of subjects: 99
Study 31218842 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant dual anti-HER2 therapy and taxane
Number of subjects: 19
Study 30021551 — intervention group
Group type: EXPERIMENTAL
Intervention: Stress Management (SM)
Number of subjects: 0
Study 30021551 — intervention group
Group type: EXPERIMENTAL
Intervention: Stress Management with Buddy (SM-B)
Number of subjects: 0
Study 30021551 — intervention group
Group type: COMPARATOR
Intervention: Control Condition (CC)
Number of subjects: 0
Study 27793446 — intervention group
Group type: EXPERIMENTAL
Intervention: Stereotactic radiotherapy of the tumor bed (SRT-TB)
Number of subjects: 59
Study 27793446 — intervention group
Group type: COMPARATOR
Intervention: Whole-brain radiotherapy (WBRT)
Number of subjects: 59
Study 23124538 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided imagery
Number of subjects: 72
Study 23124538 — intervention group
Group type: COMPARATOR
Intervention: Usual care control
Number of subjects: 72
Study 22592572 — intervention group
Group type: EXPERIMENTAL
Intervention: 1000 mg vitamin C daily
Number of subjects: 60
Study 22592572 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 19860602 — intervention group
Group type: EXPERIMENTAL
Intervention: Outpatient-based exercise programme at 8 weeks post-surgery
Number of subjects: 100
Study 19860602 — intervention group
Group type: EXPERIMENTAL
Intervention: Performance in 6MWT at 8 weeks
Number of subjects: 100
Study 18689550 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of diet and exercise (DE)
Number of subjects: 90
Study 18689550 — intervention group
Group type: COMPARATOR
Intervention: Diet alone (D)
Number of subjects: 90
Study 18689550 — intervention group
Group type: COMPARATOR
Intervention: Exercise alone (E)
Number of subjects: 90
Study 15311026 — intervention group
Group type: EXPERIMENTAL
Intervention: HoLEP
Number of subjects: 200
Study 15311026 — intervention group
Group type: COMPARATOR
Intervention: TURP
Number of subjects: 200
Study 11433088 — intervention group
Group type: COMPARATOR
Intervention: CT (Conventional Treatment)
Number of subjects: 212
Study 11433088 — intervention group
Group type: EXPERIMENTAL
Intervention: CTM (Conventional Treatment with 2 Anorectal Manometry sessions)
Number of subjects: 212
Study 9609557 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotic therapy with glucocorticoids
Number of subjects: 509
Study 9609557 — intervention group
Group type: COMPARATOR
Intervention: Antibiotic therapy without glucocorticoids
Number of subjects: 509
Study 9609557 — intervention group
Group type: EXPERIMENTAL
Intervention: Logistic regression analysis
Number of subjects: 509
Study 8054247 — intervention group
Group type: EXPERIMENTAL
Intervention: Zidovudine (ZDV) 250 mg orally
Number of subjects: 8
Study 8054247 — intervention group
Group type: EXPERIMENTAL
Intervention: Dideoxyinosine (ddI) 250 mg orally
Number of subjects: 8
Study 8054247 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of ZDV 250 mg plus ddI 250 mg orally
Number of subjects: 8
Study 2455426 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical minoxidil lotion (2% and 5%)
Number of subjects: 9
Study 2455426 — intervention group
Group type: COMPARATOR
Intervention: Placebo minoxidil lotion
Number of subjects: 9
Study 29734977 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 1: positive airway pressure flow (PAP flow), chest and abdominal effort, and snoring
Number of subjects: 65
Study 29734977 — intervention group
Group type: COMPARATOR
Intervention: Group 2: smoothed PAP flow and effort (CW‐EMG‐EF)
Number of subjects: 65
Study 28772041 — intervention group
Group type: EXPERIMENTAL
Intervention: Ferric carboxymaltose (FCM) therapy
Number of subjects: 1000
Study 26280577 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose aspirin (LDA)
Number of subjects: 1078
Study 24477734 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic walking exercise
Number of subjects: 22
Study 24477734 — intervention group
Group type: COMPARATOR
Intervention: Stretching exercise
Number of subjects: 22
Study 20658529 — intervention group
Group type: EXPERIMENTAL
Intervention: Imiquimod treatment
Number of subjects: 0
Study 20658529 — intervention group
Group type: EXPERIMENTAL
Intervention: Frequent NSAID-use
Number of subjects: 0
Study 20658529 — intervention group
Group type: EXPERIMENTAL
Intervention: NSAID-use
Number of subjects: 0
Study 18345708 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevacizumab plus interferon-alpha-2a
Number of subjects: 1381
Study 18345708 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus interferon-alpha-2a
Number of subjects: 1381
Study 16447103 — intervention group
Group type: EXPERIMENTAL
Intervention: Linezolid
Number of subjects: 604
Study 16447103 — intervention group
Group type: COMPARATOR
Intervention: Vancomycin
Number of subjects: 604
Study 14633566 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined general and epidural anesthesia
Number of subjects: 30
Study 14633566 — intervention group
Group type: COMPARATOR
Intervention: General anesthesia
Number of subjects: 30
Study 10847236 — intervention group
Group type: EXPERIMENTAL
Intervention: Elevated homocysteine
Number of subjects: 101
Study 10847236 — intervention group
Group type: EXPERIMENTAL
Intervention: MTHFR mutation (677 C‐‐>T)
Number of subjects: 101
Study 10847236 — intervention group
Group type: EXPERIMENTAL
Intervention: Decreased activated protein C resistance ratio
Number of subjects: 101
Study 10847236 — intervention group
Group type: EXPERIMENTAL
Intervention: Decreased protein C levels
Number of subjects: 101
Study 10847236 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of two risk factors
Number of subjects: 101
Study 10847236 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of three risk factors
Number of subjects: 101
Study 9342007 — intervention group
Group type: EXPERIMENTAL
Intervention: Second-generation assay for cardiac troponin T (cTnT) on the Enzymun system
Number of subjects: 0
Study 9342007 — intervention group
Group type: COMPARATOR
Intervention: First-generation assay for cardiac troponin T (cTnT)
Number of subjects: 0
Study 9342007 — intervention group
Group type: EXPERIMENTAL
Intervention: Second-generation assay for cardiac troponin T (cTnT)
Number of subjects: 0
Study 8170796 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive muscle relaxation training
Number of subjects: 15
Study 8170796 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 15
Study 3535017 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine
Number of subjects: 0
Study 3535017 — intervention group
Group type: COMPARATOR
Intervention: Colloidal bismuth subcitrate (CBS)
Number of subjects: 0
Study 31038012 — intervention group
Group type: EXPERIMENTAL
Intervention: RESCUE intervention (problem-solving and skills-building intervention for stroke caregivers)
Number of subjects: 0